Landmark clinical trials have shown that Jardiance significantly reduces the risk of cardiovascular events (like heart attacks and strokes) and hospitalization for heart failure in patients with type 2 diabetes and established heart disease
The warning letters sent to manufacturers of the products note that HCG has not received FDA approval for any weight loss indication
LC revised the manuscript
Notably, treatment with Mildronate (3-(2,2,2-trimethylhydrazinium) propionate), a specific inhibitor of L-carnitine biosynthesis and transport, significantly reduced the formation of red lesions without affecting white lesions
Sepand, M.H
Poon JL, Marshall C, Johnson C, Pegram H, Hunter M, Kan H, Ahmad N